New Key Statistics Module, Z-Score and F-Score
NAS:VRAX Key Ratios
| Market Cap $ M | 10.51 |
| Enterprise Value $ M | 3.37 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.22 |
| Price/Sales | 63.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.61 |
| Beneish M-Score | 11.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.51 |
| EV-to-EBITDA | -0.52 |
| PEG | -- |
| Shares Outstanding M | 4.34 |
| Net Margin (%) | -7,741.18 |
| Operating Margin % | -7,387.06 |
| Pre-tax Margin (%) | -7,903.53 |
| Quick Ratio | 11.39 |
| Current Ratio | 11.57 |
| ROA % (ttm) | -89.92 |
| ROE % (ttm) | -97.03 |
| ROIC % (ttm) | -379.77 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.46 |
VRAX Number of Guru Trades
VRAX Volume of Guru Trades
Gurus Latest Trades with NAS:VRAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRAX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Virax Biolabs Group Ltd Insider Transactions
No Available Data
News about NAS:VRAX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers